Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography

Neurology

Volumn 47, Issue 4, 1996, Pages 1015-1020

  Boundy, K L ^a   Rowe, C C ^a   Black, A B ^a   Kitchener, M I ^a   Barnden, L R ^a   Sebben, R ^a   Kneebone, A ^a   Kassiou, M ^b   Katsifis, A ^b   Lambrecht, R ^b   Boundy, Karyn L ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN RECEPTOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 123; IODODEXETIMIDE; MUSCARINIC RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; DIAGNOSTIC ACCURACY; EPILEPTIC FOCUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY;

EID: 10244224134     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.4.1015     Document Type: Article

References (35)

1. Yaari Y, Jensen MS. Two types of epileptic foci generating brief and sustained paroxysms in the in-vitro rat hippocampus. Epilepsy Res 1992;8(Suppl.):263-269.
2. Byrne MC, Gottlieb R, McNamara JO. Amygdala kindling induces muscarinic cholinergic receptor decline in a highly specific distribution within the limbic system. Exp Neurol 1980;69:85-98.
3. McNamara JO. Muscarinic cholinergic receptors participate in the kindling models of epilepsy. Brain Res 1978;154:415-420.
4. Fitz JG, McNamara JO. Muscarinic cholinergic regulation of epileptic spiking in kindling. Brain Res 1979;178:117-127.
5. Delgado-Escueta AV, Ward AA, Woodbury DM, Porter RJ. New wave of research in the epilepsies. Adv Neurol 1986;44: 1-45.
6. Wyler AR, Nadi NS, Porter RJ. Acetyl choline, GABA, benzodiazepine, and glutamate receptors in the temporal lobe of epileptic patients [abstract]. Neurology 1987;37(Suppl. 1):103.
7. Wilson AA, Scheffel UA, Dannals RF, Sthathis M, Ravert HT, Wagner HN Jr. In vivo biodistribution of two (18F)-labelled muscarinic cholinergic receptor ligands: 2-(18F)- and 4-(18F)-fluorodexetimide. Life Sci 1991;48:1385-1394.
8. Muller-Gartner HW, Wilson AA, Dannals RF, et al. Imaging muscarinic cholinergic receptors in human brain in vivo with SPECT, I-123-4-iododexetimide. J Cereb Blood Flow Metab 1992;12:562-570.
9. Eckelman WC, Eng R, Rzeszitarski WJ, Gibson RE, Francis B, Reba RC. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding tracer. J Nucl Med 1985;26:637-642.
10. Laduron PM, Janssen PFM. Characterisation and subcellular localisation of brain muscarinic receptors labelled in vivo by H-3-dexetimide. J Neurochem 1979;32:421-427.
11. Laduron PM, Verwimp M, Leyson JE. Stereospecific in vitro binding of H-3 dexetimide to brain muscarinic receptors. J Neurochem 1978;33:1223-1231.
12. Wilson AA, Dannals R, Ravert J. Synthesis and biological evaluation of I-123 and I-124 iododexetimide, a potent muscarinic cholinergic receptor antagonist. J Med Chem 1989;32: 1057-1062.
13. Boundy KL, Barnden LR, Rowe CC, et al. Human dosimetry and normal brain distribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors. J Nucl Med 1995;36:1332-1336.
14. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota, 1940-1980. Epilepsia 1991b;32:429-445.
15. Engel J Jr, Van Ness P, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies, 2nd ed. New York; Raven Press, 1993:609-621.
16. Newton MR, Berkovic SF, Austin MC, Rowe CC, McKay WJ, Bladin PF. Ietal, postictal and interictal SPECT in the lateralization of temporal lobe epilepsy. Eur J Nuc Med 1994;21: 1067-1071.
17. Newton MR, Berkovic SF, Austin MC, Reutens DC, McKay WJ, Bladin PF. Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology 1992; 42:371-377.
18. Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GCA, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990;40: 1869-1875.
19. Rowe CC, Kitchener MI, Lam J, Black AB. High resolution interictal and periictal Tc-99m hexametazine SPECT for seizure localisation. Aust N Z J Med 1994;23(Suppl. 1):509.
20. Newton MR, Berkovic SF, Austin MC, Rowe CC, McKay WJ, Bladin PF. SPECT in the localisation of extratemporal and temporal seizure foci. J Neurol Neurosurg Psychiatry 1992;55: 891-894.
21. Henry TR, Chugani HT, Abou-Khalil BW, Theodore WH, Swartz BE. Positron emission tomography. In: Engel J Jr, ed. Surgical treatment of the epilepsies, 2nd ed. New York: Raven Press, 1993:211-232.
22. Jibiki I, Kurokawa K, Matsude H, et al. Comparison of benzodiazepine receptor and regional cerebral blood flow imaging of foci in hippocampal kindled rabbits: a preliminary report. Pharmacol Biochem Behav 1994;48:553-556.
23. Cordes M, Henkes H, Fentl F, et al. Evaluation of focal epilepsy: a SPECT scanning comparison of I-123-I iomazenil vs HMPAO. AJNR Am J Neuroradiol 1992;13:249-253.
24. Duncan S, Gillen GJ, Brodie MJ. Lack of effect of concomitant clobazam on interictal I-123 iomazenil SPECT. Epilepsy Res 1993;15:61-66.
25. Mayberg HS, Sadzot B, Meltzer CC, et al. Quantification of Mu and non-Mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 1991;30:3-11.
26. Muller-Gartner HW, Mayberg HS, Fisher RS, et al. Decreased hippocampal muscarinic cholinergic receptor binding measured by 123-iododexetimide and single photon emission computed tomography in epilepsy. Ann Neurol 1993;34:235-238.
27. Davies P, Verth AH. Regional distribution of muscarinic acetylcholinergic receptors in normal and Alzheimer's type dementia brains. Brain Res 1979;138:389-392.
28. Sloviter RS. The functional organisation of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 1994;35:640-654.
29. Burdette DE, Sakuarai SY, Henry TR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995;45:934-941.
30. Al Tikriti MS, Dey HM, Zoghbi SS, et al. Dual isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion. Eur J Nucl Med 1994;21:196-202.
31. Cook MJ, Fish DR, Shorvon SD, Staughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992;115:1001-1015.
32. Jackson GD, Berkovic SF, Duncan JS, Connelly D. Optimising the diagnosis of hippocampal sclerosis using MR imaging. AJNR Am J Neuroradiol 1993;14:753-762.
33. Jack CR Jr, Mullan BP, Sharborough FW, et al. Intractable nonlesional epilepsy of temporal lobe origin: lateralization by interictal SPECT versus MRI. Neurology 1994;44:829-836.
34. Jackson GD, Kuzniecky RI, Cascino GD. Hippocampal sclerosis without detectable hippocampal atrophy. Neurology 1994; 44:42-46.
35. Trennery MR, Jack CR Jr, Irnik RJ, et al. MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology 1993;43:1800-1805.